Journal profile · Chemistry-Chemistry (miscellaneous)
European Journal of Medicinal Chemistry Reports
ISSN 2772-4174 · Elsevier · France
European Journal of Medicinal Chemistry Reports: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 6.7 (journal website); fully open access; APC about USD 2,400; review about 67 days (submission to acceptance, publisher); 78 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
European Journal of Medicinal Chemistry Reports is published by Elsevier and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Synthesis and biological activity, Computational Drug Discovery Methods and Click Chemistry and Applications, together about 36.2% of its articles. Its main subfields are Organic Chemistry and Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
EJMCR (European Journal of Medicinal Chemistry Reports) is an open access companion title to European Journal of Medicinal Chemistry.EJMCR publishes all aspects of medicinal chemistry with a focus on drug discovery. It provides a forum for medicinal chemists both from academia and from industry to share new results and the state of the art via the publication of full research papers, reviews, microarticles and short communications. Key aspects of the scope include but are not limited to:Biologically active compoundsDrug targetingDrug-receptor interactionsMolecular aspects of biologically active compounds metabolismDrug delivery systemsHit discoveryPharmacological evaluation of known biologically active compoundsNatural productsTraditional Chinese Medicine (TCM)Novel methodology (including computational strategies and tools) and database, structural biological studies (X-ray, NMR, etc.) of relevant ligands and targets with application to medicinal chemistry
From the journal's Aims & Scope
Research area (LetPub): Chemistry-Chemistry (miscellaneous)
Editor-in-chief René CsukPublisher website
Editorial board by country: 4 in mainland China (about 17%); most named France 5, Mainland China 4, India 4, United States 2, Italy 2 (23 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Synthesis and biological activityChemistry18%
- Computational Drug Discovery MethodsComputer Science10.2%
- Click Chemistry and ApplicationsChemistry8%
- Cholinesterase and Neurodegenerative DiseasesMedicine5.7%
- Synthesis and Biological EvaluationChemistry5.5%
- Natural product bioactivities and synthesisBiochemistry, Genetics and Molecular Biology4%
- Cancer therapeutics and mechanismsBiochemistry, Genetics and Molecular Biology4%
- Multicomponent Synthesis of HeterocyclesChemistry3.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Chemistry, Medicinal | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Chemistry, Medicinal | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 6.7Publisher website ·
- CiteScore 2026-06
- 8.5LetPub ·
- CiteScore (publisher)
- 8.5Publisher website ·
- SJR 2026-06
- 0.9LetPub ·
- SNIP 2026-06
- 1.37LetPub ·
- h-index
- 28OpenAlex ·
- i10-index
- 105OpenAlex ·
- 2-year mean citedness
- 6.28OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 74LetPub ·
Articles by year OpenAlex count · 366 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 54 | 54 | 14 |
| 2025 | 78 | 78 | 197 |
| 2024 | 115 | 115 | 1,341 |
| 2023 | 28 | 28 | 222 |
| 2022 | 71 | 71 | 1,206 |
| 2021 | 20 | 20 | 342 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
67 dayssubmission to acceptance · community reports about 16 weeks
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Average review time (community reports)
- about 16 weeksLetPub ·
- Submission to first decision
- 2 daysPublisher website ·
- First decision after review
- 34 daysPublisher website ·
- Submission to acceptance
- 67 daysPublisher website ·
- Acceptance to publication
- 3 daysPublisher website ·
- Submission to publication (journal-reported)
- about 11 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,400 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 1,870 / EUR 1,750 / GBP 1,500 / JPY 231,940 | — | — | |
| LetPub | USD 1,500 | Yes | — | |
| Publisher website | USD 2,880 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted5
- original research articleThis journal accepts two types of manuscripts:Original Research articles:These articles present a complete study that is to say that they should contain the syn…Length not stated
- original research articlesOriginal Research articles: These articles present a complete study that is to say that they should contain the synthesis and evaluation of new compounds.Length not stated
- reviewThis journal accepts two types of manuscripts:Original Research articles:These articles present a complete study that is to say that they should contain the syn…Length not stated
- review articleThis journal accepts two types of manuscripts:Original Research articles:These articles present a complete study that is to say that they should contain the syn…Length not stated
- review articlesReview articles: These types of papers should review the recent literature of any field within medicinal chemistry.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- France
- Language
- English
- ISSN
- 2772-4174
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about European Journal of Medicinal Chemistry Reports
What CAS zone is European Journal of Medicinal Chemistry Reports in?
In the 2025 upgraded edition of the CAS Journal Ranking, European Journal of Medicinal Chemistry Reports is in Zone 3 of Medicine, and in Zone 3 of the minor category Chemistry, Medicinal. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of European Journal of Medicinal Chemistry Reports?
The journal's website gives an impact factor of 6.7; this is the journal's own figure, as LetPub lists none for it; CiteScore 8.5, h-index 28.
How long does peer review take at European Journal of Medicinal Chemistry Reports?
The publisher reports about 67 days (submission to acceptance); authors report an average review time of about 16 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of European Journal of Medicinal Chemistry Reports based?
Of the 23 board members whose country the journal's board page names, 4 (about 17%) are in mainland China; the countries named most often are France (5), Mainland China (4) and India (4). Counted from the institutions listed on the board page; for reference only.
Which databases index European Journal of Medicinal Chemistry Reports?
According to LetPub and DOAJ records, European Journal of Medicinal Chemistry Reports is indexed in ESCI, Scopus and DOAJ.
Is European Journal of Medicinal Chemistry Reports open access, and what is the APC?
European Journal of Medicinal Chemistry Reports is a fully open-access journal. APC about USD 2,400.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .